Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > New University of BC clinical study site for phase 2 launch

<< Previous

Bullboard Posts

Next >>

Comment by frebeach1on Dec 07, 2020 10:41am

152 Views

Post# 32049010

RE:RE:RE:New University of BC clinical study site for phase 2 launch

A Nobel prize winner among others, for sure.

Long time holder from Bare Oaks.
Dave

gojotv! wrote:

Very excited to hear this news! I had the pleasure of attending a lecture by Dr. Sherri MacFarland at UBC last year where she discussed her anti-cancer photodynamic compounds and her latest work with anti-bacterial compouns for dental hygiene use.
I must say, investors may or may not fully appreciate the depth and breadth of application of Dr. MacFarland's work, but around UBC, where they grasp the Science of it, she was being escorted around like a rock star.
GLTA real investors and cancer fighters!

enriquesuave wrote: Nice more patients treated and seems like TMO is still on for December very possibly. If more patients were enrolled we may see another few patients treated in the next 2 weeks IMO.